Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cyril Sobolewski

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Biomolecules|August 6, 2021
Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-CelecoxibCyril Sobolewski, Noémie Legrand
PPAR Research|February 8, 2017
MicroRNAs-Dependent Regulation of PPARs in Metabolic Diseases and CancersDorothea Portius, Cyril Sobolewski, Michelangelo Foti
Cancers|July 27, 2022
MicroRNAs, Tristetraprolin Family Members and HuR: A Complex Interplay Controlling Cancer-Related ProcessesCyril Sobolewski, Laurent Dubuquoy, Noémie Legrand
International Journal of Molecular Sciences|September 10, 2021
The Emerging Role of Stress Granules in Hepatocellular CarcinomaDobrochna Dolicka, Michelangelo Foti, Cyril Sobolewski
World Journal of Gastroenterology|September 30, 2020
Stress granules in colorectal cancer: Current knowledge and potential therapeutic applicationsNoémie Legrand, Dan A Dixon, Cyril Sobolewski
World Journal of Gastrointestinal Oncology|February 22, 2019
AU-rich element-binding proteins in colorectal cancerNoémie Legrand, Dan A Dixon, Cyril Sobolewski
Biochemical Pharmacology|July 10, 2010
Targeting COX-2 expression by natural compounds: a promising alternative strategy to synthetic COX-2 inhibitors for cancer chemoprevention and therapyClaudia Cerella, Cyril Sobolewski, Mario Dicato, et al.
Cell Cycle (Georgetown, Tex.)|August 25, 2011
Cox-2 inhibitors induce early c-Myc downregulation and lead to expression of differentiation markers in leukemia cellsCyril Sobolewski, Claudia Cerella, Mario Dicato, et al.
Seminars in Liver Disease|January 31, 2015
MicroRNAs in fatty liver diseaseCyril Sobolewski, Nicolas Calo, Dorothea Portius, et al.
Cancers|December 9, 2023
MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches?Mickaël Jouve, Rodolphe Carpentier, Sarra Kraiem, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Biomolecules|August 6, 2021
Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-CelecoxibCyril Sobolewski, Noémie Legrand
PPAR Research|February 8, 2017
MicroRNAs-Dependent Regulation of PPARs in Metabolic Diseases and CancersDorothea Portius, Cyril Sobolewski, Michelangelo Foti
Cancers|July 27, 2022
MicroRNAs, Tristetraprolin Family Members and HuR: A Complex Interplay Controlling Cancer-Related ProcessesCyril Sobolewski, Laurent Dubuquoy, Noémie Legrand
International Journal of Molecular Sciences|September 10, 2021
The Emerging Role of Stress Granules in Hepatocellular CarcinomaDobrochna Dolicka, Michelangelo Foti, Cyril Sobolewski
World Journal of Gastroenterology|September 30, 2020
Stress granules in colorectal cancer: Current knowledge and potential therapeutic applicationsNoémie Legrand, Dan A Dixon, Cyril Sobolewski
World Journal of Gastrointestinal Oncology|February 22, 2019
AU-rich element-binding proteins in colorectal cancerNoémie Legrand, Dan A Dixon, Cyril Sobolewski
Biochemical Pharmacology|July 10, 2010
Targeting COX-2 expression by natural compounds: a promising alternative strategy to synthetic COX-2 inhibitors for cancer chemoprevention and therapyClaudia Cerella, Cyril Sobolewski, Mario Dicato, et al.
Cell Cycle (Georgetown, Tex.)|August 25, 2011
Cox-2 inhibitors induce early c-Myc downregulation and lead to expression of differentiation markers in leukemia cellsCyril Sobolewski, Claudia Cerella, Mario Dicato, et al.
Seminars in Liver Disease|January 31, 2015
MicroRNAs in fatty liver diseaseCyril Sobolewski, Nicolas Calo, Dorothea Portius, et al.
Cancers|December 9, 2023
MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches?Mickaël Jouve, Rodolphe Carpentier, Sarra Kraiem, et al.
Pageof 4